On Feb. 4, the Food and Drug Administration (FDA) announced it is planning to assess the agency’s approach to opioid medications, in response to the opioid abuse epidemic. Read more
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications
